Institute of Psychiatry, London
14
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
7.1%
1 terminated/withdrawn out of 14 trials
87.5%
+1.0% vs industry average
29%
4 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Compassion-Focused Therapy for Distressing Mood Swings: A Case Series
Role: lead
Memantine for Agitation in Dementia
Role: collaborator
Cognitive Bias Modification Training in Adolescents Who Have Experienced Adversity
Role: lead
VR Therapy for Psychosis Negative Symptoms (V-NeST)
Role: lead
Exploring the Feasibility of Social Skills Training in People With Psychosis
Role: lead
Optimisation of Antipsychotic Drug Use in Older People
Role: lead
Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen
Role: collaborator
Developing Computerised CBT for Adults With OCD
Role: lead
Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)
Role: collaborator
Cognitive Behaviour Therapy (CBT) for Body Dysmorphic Disorder (BDD)
Role: lead
CORAL Study: Proof of Concept Trial
Role: lead
Neural Responses and Dysphoria: Modulation by a Pharmacological Probe
Role: collaborator
Study to Prevent Negative Thoughts of Life
Role: collaborator
CALM-AD
Role: lead
All 14 trials loaded